Market Overview

UPDATE: JP Morgan Initiates Health Management Associates at Neutral on Near Term Uncertainty

Related HMA
Benzinga's Volume Movers
US Stock Futures Rise Ahead Of International Trade Data

JP Morgan initiated coverage on Health Management Associates (NYSE: HMA) with a Neutral rating and a $9 price target.

JP Morgan commented, "Although reform should provide a solid boost, HMA offers relatively less upside potential from reform-based coverage expansion when compared to its peers according to our JPM Healthcare Reform Model. When this more modest EBITDA upside versus peers (~8% vs. ~10% group average) is coupled with company specific headline risks related to government investigations into admission practices and the potential for this to negatively impact future volumes as well as M&A prospects, we see HMA as a comparatively less attractive name in the group."

Health Management Associates closed at $8.28 on Monday.

Latest Ratings for HMA

DateFirmActionFromTo
Dec 2013Wells FargoDowngradesOutperformMarket Perform
Sep 2013Avondale PartnersDowngradesMarket OutperformMarket Perform
Aug 2013UBSDowngradesBuyNeutral

View More Analyst Ratings for HMA
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (HMA)

Around the Web, We're Loving...

Get Benzinga's Newsletters